Clinical Trials Browser

Has results × Glioblastoma × Re-Irradiation × Clear all

NCT03661723 2024-09-19

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Phase 2 Completed

60 enrolled 23 charts

Glioblastoma